Search
Cellectar Biosciences Inc
CLRBAdd to Watchlist
2.090USD
-0.140-6.28%
Close 09-23 16:00（ET）
16.70MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-6.28%
5 Days
-11.06%
1 Month
-19.31%
6 Months
-33.01%
Year to Date
-29.15%
1 Year
-59.81%
Key Figures
2.250Open
2.370High
2.29KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
2.230Prev. Close
2.080Low
4.99KTurnover
LossP/E Static
0.56P/B
0.00%Div Yield TTM
-153.46%ROA
6.52052wk High
0.03Volume Ratio
-44.58MNet Profit
7.99MShares
-5.3883EPS TTM
0.50Beta
-395.20%ROE
2.08052wk Low
13.00%Amplitude
--Gross Margin
16.70MMarket Cap
0.64Reward/Risk
4.94%Risk Rate
Cellectar Biosciences Inc's Score
0.05vs previous score
Forecast8.50
Financial Health7.19
Technical3.63
Valuation Dimensions6.92
Institutional Confidence3.00
Risk Assessment--
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Cellectar Biosciences Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Cellectar Biosciences Inc Latest Earnings Call Transcripts
Cellectar Biosciences (CLRB) Q2 2026 Earnings Call: Phase III Startup and 2027 NDA Plan
Cellectar Biosciences’ Q2 2026 earnings call covered $34.0 million in cash, iopofosine Phase III startup, 2027 NDA plans and CLR 125 progress.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.57/-0.48
Revenue / Forecast
--/0.00
Cellectar Biosciences Inc Profile
SectorPharmaceuticals
Ticker SymbolCLRB
Number of employees11
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Hexstone Capital LLC | 1.57% |
| Bleichroeder LP | 1.25% |
| Vanguard Capital Management, LLC | 1.03% |
| DRW Securities, LLC | 0.57% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 3.90% |
| Corporation | 1.69% |
| Individual Investor | 0.39% |
| Investment Advisor/Hedge Fund | 0.36% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%
FAQs
What is the current price of Cellectar Biosciences Inc (CLRB)?
The current price of Cellectar Biosciences Inc (CLRB) is 2.09.
What is the symbol of Cellectar Biosciences Inc?
The ticker symbol of Cellectar Biosciences Inc is CLRB.
What is the 52-week high of Cellectar Biosciences Inc?
The 52-week high of Cellectar Biosciences Inc is 6.52.
What is the 52-week low of Cellectar Biosciences Inc?
The 52-week low of Cellectar Biosciences Inc is 2.08.
What is the market capitalization of Cellectar Biosciences Inc?
The market capitalization of Cellectar Biosciences Inc is 16.70M.
Is Cellectar Biosciences Inc (CLRB) currently rated as Buy, Hold, or Sell?
According to analysts, Cellectar Biosciences Inc (CLRB) has an overall rating of Buy, with a price target of 11.50.
What is the Earnings Per Share (EPS TTM) of Cellectar Biosciences Inc (CLRB)?
The Earnings Per Share (EPS TTM) of Cellectar Biosciences Inc (CLRB) is -5.39.